Publication
Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
dc.contributor.author | Farinha, Filipa | |
dc.contributor.author | Pepper, Ruth J | |
dc.contributor.author | Oliveira, Daniel G | |
dc.contributor.author | McDonnell, Thomas | |
dc.contributor.author | Isenberg, David A | |
dc.contributor.author | Rahman, Anisur | |
dc.date.accessioned | 2022-07-12T12:37:25Z | |
dc.date.available | 2022-07-12T12:37:25Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Objectives: To compare membranous lupus nephritis (MLN) and proliferative lupus nephritis (PLN) with respect to survival, demographic, clinical and laboratory characteristics; and to investigate predictors of renal and patient survival. Methods: Single-centre retrospective observational study. Patients with biopsy-proven PLN, MLN and mixed lupus nephritis were included. Groups were compared using appropriate statistical tests and survival was analysed through the Kaplan-Meier method. Cox regression analysis was performed to investigate predictors of renal and patient survival. Results: A total of 187 patients with biopsy-proven lupus nephritis (135 with PLN, 38 with MLN and 14 with mixed LN) were followed for up to 42 years (median 12 years). There was a higher proportion of MLN amongst Afro-Caribbeans than amongst Caucasians (31% vs 15%, P = 0.010). Patients with MLN had significantly lower anti-dsDNA antibodies (P = 0.001) and higher C3 levels (P = 0.018) at diagnosis. Cumulative renal survival rates at 5, 10, 15 and 20 years were 91, 81, 75 and 66% for PLN and 100, 97, 92 and 84% for MLN, respectively (P = 0.028). Cumulative patient survival at 5, 10, 15 and 20 years was 94, 86, 80 and 76%, with no difference between PLN and MLN. Urinary protein-creatinine ratio above 42 mg/mmol and eGFR below 76 ml/min/1.73 m2, one year after the diagnosis of LN, were the strongest predictors of progression to end-stage renal disease. eGFR below 77 ml/min/1.73 m2, at one year, development of end-stage renal disease and Afro-Caribbean ethnicity were associated with higher mortality. Conclusion: Patients with MLN and PLN differ significantly regarding serological profiles and renal survival, suggesting different pathogenesis. Renal function at year one predicts renal and patient survival. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Farinha F, Pepper RJ, Oliveira DG, McDonnell T, Isenberg DA, Rahman A. Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up. Rheumatology (Oxford). 2020;59(11):3314-3323. doi:10.1093/rheumatology/keaa103 | pt_PT |
dc.identifier.doi | 10.1093/rheumatology/keaa103 | pt_PT |
dc.identifier.issn | 1462-0324 | |
dc.identifier.issn | 1462-0332 | |
dc.identifier.uri | http://hdl.handle.net/10400.16/2714 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Oxford University Press | pt_PT |
dc.relation.publisherversion | https://academic.oup.com/rheumatology/article/59/11/3314/5821466?login=false | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | lupus nephritis | pt_PT |
dc.subject | outcomes | pt_PT |
dc.subject | survival | pt_PT |
dc.subject | Systemic lupus erythematosus | pt_PT |
dc.title | Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | England | pt_PT |
oaire.citation.endPage | 3323 | pt_PT |
oaire.citation.issue | 11 | pt_PT |
oaire.citation.startPage | 3314 | pt_PT |
oaire.citation.title | Rheumatology | pt_PT |
oaire.citation.volume | 59 | pt_PT |
person.familyName | Guimarães Tato Ramos de Oliveira | |
person.givenName | Daniel Filipe | |
person.identifier.ciencia-id | 4C10-BF46-FD75 | |
person.identifier.orcid | 0000-0002-3561-0250 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 8ed9ffd4-2be9-4808-a20c-1de926ad2257 | |
relation.isAuthorOfPublication.latestForDiscovery | 8ed9ffd4-2be9-4808-a20c-1de926ad2257 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Farinha-2020-Outcomes-of-membranous-and-prolifer.pdf
- Size:
- 488.15 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.35 KB
- Format:
- Item-specific license agreed upon to submission
- Description: